Medical therapy of endocrine carcinomas. Part II: Malignant gastrinomas, insulinomas, glucagonomas, carcinoids und other carcinomas;Medikamentose therapie endokriner karzinome. Teil II: Maligne gastrinome, insulinome, glukagonome, karzinoide und andere tumoren

Medizinische Klinik

Volumn 95, Issue 2, 2000, Pages 81-84

  Schott, Matthias ^a   Scherbaum, Werner A ^b   Feldkamp, Joachim ^b  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b NONE

Author keywords

Carcinoids; Chemotherapy; Endocrine carcinomas; Gastrinoma; Immunotherapy; Insulinoma

Indexed keywords

CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; FLUOROURACIL; STREPTOZOCIN; ANTINEOPLASTIC AGENT; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; DRUG DERIVATIVE; OCTREOTIDE; SOMATOSTATIN;

ADRENAL CANCER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RESISTANCE; CARCINOID; DIGESTIVE SYSTEM CANCER; ENDOCRINE TUMOR; GASTRINOMA; GLUCAGONOMA; HUMAN; INSULINOMA; PRACTICE GUIDELINE; REVIEW; THYROID CANCER; DOSE RESPONSE; GASTROINTESTINAL TUMOR; NEOPLASM;

ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, HORMONAL; CARCINOID TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; GASTRINOMA; GASTROINTESTINAL NEOPLASMS; GLUCAGONOMA; HUMANS; INSULINOMA; NEOPLASMS, HORMONE-DEPENDENT; OCTREOTIDE; SOMATOSTATIN;

EID: 0034651235     PISSN: 07235003     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03044988     Document Type: Review

References (49)

1. Ajani JA, Carrasco CH, Charnsangavej C. et al. Islet cell tumors metastatic to the liver: effective palliation by sequential hepatic artery embolization. Ann Intern Med 1988;108:340-4.
2. Bajetta E, Rimassa L, Carnaghi C, et al. 5-fluorouracil, dacarbazine. and epirubicin in the treatment of patients with neuroendocrine tumors. Cancer 1998;83:372-8.
3. Bajetta E, Zilembo N, Di BM, et al. Treatment of metastatic carcinoids and other neuroendocrine tumors with recombinant interferon-alpha-2a. A study by the Italian Trials in Medical Oncology Group. Cancer 1993;72:3099-105.
4. Boden G. Glucagonomas and insulinomas. Gastroenterol Clin North Am 1989;18:831-45.
5. Bukowski RM, Johnson KC, Peterson RK, et al. A phase II trial of combination chemotherapy in patients with metastatic carcinoid tumors. A Southwest Oncology Group Study. Cancer 1987;60:2891-5.
6. Capella C, Polak JM, Buffa R, et al. Morphologic patterns and diagnostic criteria of VIP-producing endocrine tumors. A histologic, histochemical. ultrastructural, and biochemical study of 32 cases. Cancer 1983;52:1860-74.
7. Carrasco CH, Chuang VP, Wallace S. Apudomas metastatic to the liver: treatment by hepatic artery embolization. Radiology 1983;149:79-83.
8. Creutzfeldt W, Arnold R, Creutzfeldt C, et al. Pathomorphologic, biochemical, and diagnostic aspects of gastrinomas (Zollinger-Ellison syndrome). Hum Pathol 1975;6:47-76.
9. Delcore R, Cheung LY, Friesen SR. Characteristics of duodenal wall gastrinomas. Am J Surg 1990;160:621-3.
10. Engstrom PF, Lavin PT, Moertel CG, et al. Streptozocin plus fluorouracil versus doxorubicin therapy for metastatic carcinoid tumor. J Clin Oncol 1984;2:1255-9.
11. Eriksson B, Oberg K, Alm G, et al. Treatment of malignant endocrine pancreatic tumours with human leucocyte interferon. Lancet 1986;2:1307-9.
12. Godwin JD. Carcinoid tumors. An analysis of 2,837 cases. Cancer 1975;36:560-9.
13. Johnson JA, Fabri PJ, Lott JA. Serum gastrins in Zollinger-Ellison syndrome: identification of localized discase. Clin Chem 1980;26:867-70.
14. Keane TJ, Rider WD, Harwood AR, et al. Whole abdominal radiation in the management of metastatic gastrointestinal carcinoid tumor. Int J Radiat Oucol Biol Phys 1981;7:1519-21.
15. Kvols LK. Therapy of the malignant carcinoid syndrome. Endocrinol Metab Clin North Am 1989;18:557-68.
16. Kvols LK, Buck M. Chemotherapy of metastatic carcinoid and islet cell tumors. A review. Am J Med 1987; 82:77-83.
17. Kvols LK, Buck M, Moertel CC, et al. Treatment of metastatic islet cell carcinoma with a somatostatin analogue (SMS 201-995). Ann Intern Med 1987;107:162-8.
18. Kvols LK, Moertel CG, O'Connell MJ, et al. Treatment of the malignant carcinoid syndrome. Evaluation of a long-acting somatostatin analogue. N Engl J Med 1986;315:663-6.
19. Leichter SB. Clinical and metabolic aspects of glucagonoma. Medicine (Baltimore) 1980;59:100-13.
20. Makridis C, Ekbom A, Bring J, et al. Survival and daily physical activity in patients treated for advanced midgut carcinoid tumors. Surgery 1997;122:1075-82.
21. Makridis C, Oberg K, Juhlin C, et al. Surgical treatment of mid-gut carcinoid tumors. World J Surg 1990;14:377-83.
22. Marlink RG, Lokich JJ, Robins JR, et al. Hepatic arterial embolization for metastatic hormone-secreting tumors. Technique, effectiveness, and complications. Cancer 1990;65:2227-32.
23. Maton PN. The use of the long-acting somatostatin analogue, octreotide acetate, in patients with islet cell tumors. Gastroenterol Clin North Am 1989;18:897-922.
24. Maton PN, Camilleri M, Griffin G, et al. Role of hepatic arterial embolisation in the carcinoid syndrome. Br Med J Clin Res Ed 1983;287:932-5.
25. Metz DC, Pisegna JR, Fishbeyn VA, et al. Control of gastric acid hypersecretion in the management of patients with Zollinger-Ellison syndrome. World J Surg 1993; 17:468-80.
26. Mignon M, Ruszniewski P, Haffar S, et al. Current approach to the management of tumoral process in patients with gastrinoma. World J Surg 1986:10:703-10.
27. Moertel CG. Karnofsky memorial lecture. An odyssey in the land of small tumors. J Clin Oncol 1987;5:1502-22.
28. Moertel CG, Dockerty MB, Judd ES. Carcinoid tumors of the vermiform appendix. Cancer 1968;21:270-8.
29. Moertel CG, Hanley JA, Johnson LA, Streptozocin alone compared with streptozocin plus fluorouracil in the treatment of advanced islet-cell carcinoma. N Engl J Med 1980;303:1189-94.
30. Moertel CG, Rubin J, O'Connell MJ. Phase II study of cisplatin therapy in patients with metastatic carcinoid tumor and the malignant carcinoid syndrome. Cancer Treat Rep 1986;70:1459-60.
31. Norton JA, Doppman JL, Collen MJ, et al. Prospective study of gastrinoma localization and resection in patients with Zollinger-Ellison syndrome. Ann Surg 1986;204:468-79.
32. Norton JA, Doppman JL, Jensen RT. Curative resection in Zollinger-Ellison syndrome. Results of a 10-year prospective study. Ann Surg 1992;215:8-18.
33. Oberg K, Norheim I, Alm G. Treatment of malignant carcinoid tumors: a randomized controlled study of streptozocin plus 5-FU and human leukocyte interferon. Eur J Cancer Clin Oncol 1989;25:1475-9.
34. Oberg K, Norheim I, Lind E, et al. Treatment of malignant carcinoid tumors with human leukocyte interferon: long-term results. Cancer Treat Rep 1986;70:1297-304.
35. Ollivier S, Fonck M, Becouarn Y, et al. Dacarbazine, fluorouracil, and leucovorin in patients with advanced neuroendocrine tumors: a phase II trial. Am J Clin Oncol 1998;21:237-40.
36. Pipeleers MM, Somers G, Willems G, et al. Gastrinomas in the duodenums of patients with multiple endocrine neoplisia type 1 and the Zollinger-Ellison syndrome. N Engl J Med 1990;322:723-7.
37. Pisegna JR, Slimak GG, Doppman JL, et al. An evaluation of human recombinant alpha interferon in patients with metastatic gastrinoma. Gastroenterology 1993; 105: 1179-83.
38. Reubi JC. A somatostatin analogue inhibits chondrosarcoma and insulinoma tumour growth. Acta Endocrinol (Copenh) 1985;109:108-14.
39. Sano T, Asa SL, Kovacs K. Growth hormone-releasing hormone-producing tumors: clinical, biochemical, and morphological manifestations. Endocr Rev 1988; 9:357-73.
40. Stabile BF, Morrow DJ, Passaro E. The gastrinoma triangle: operative implications. Am J Surg 1984;147:25-31.
41. Thom AK, Norton JA, Axiotis CA, et al. Location, incidence, and malignant potential of duodenal gastrinomas. Surgery 1991;110:1086-91.
42. Thompson GB, van HJ, Martin-JK J, et al. Carcinoid tumors of the gastrointestinal tract: presentation, management, and prognosis. Surgery 1985:98:1054-63.
43. Trautmann ME, Koop H, Arnold R. What is guaranteed in the treatment of gastrointestinal endocrine tumors? Internist (Berlin) 1993;34:43-50.
44. Valette PJ, Souquet JC. Pancreatic islet cell tumors metastatic to the liver: treatment by hepatic artery chemo-embolization. Norm Res 1989;32:77-9.
45. van HG, Rubin J, Moertel CG. Treatment of metastatic carcinoid tumor with dactinomycin or dacarbazme. Cancer Treat Rep 1983;67:583-5.
46. Vinayek R, Frucht H, Chiang HC, et al. Zollinger-Ellison syndrome. Recent advances in the management of the gastrinoma. Gastroenterol Clin North Am 1990;19:197-217.
47. Vinik AI, Strodel WE, Eckhauser FE. et al. Somatostatinomas, PPomas, neurotensinomas. Semin Oncol 1987;14:263-81.
48. von ST, Howard JM, Doppman JL, et al. Prospective study of chemotherapy in patients with metastatic gastrinoma. Gastroenterology 1988;94:1326-34.
49. Wu PC, Alexander HR, Bartlett DL, et al. A prospective analysis of the frequency, location, and curability of ectopic (nonpancreaticoduodenal, nonnodal) gastrinoma. Surgery 1997;122:1176-82.